EZH2 and urinary bladder carcinoma: Another study showed that the association between the increased expression of H19 and EZH2 enhancers in patients with bladder cancer caused the stimulation of Wnt/p-catenin pathway, resulting in the down-regulation of E-cadherin, thus promoting the metastasis of bladder cancer cells (24).